OMER Q4 2016 Earnings — Omeros Corporation Revenue & Financial Results | Market Cap Arena

OMEROmeros Corporation

$821M

Q4 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$13M+93.3% YoY

Gross Profit

$13M97.1% margin

Operating Income

-$12M-91.9% margin

Net Income

-$20M-152.1% margin

EPS (Diluted)

$-0.45

QoQ Revenue Growth

+14.3%

Cash Flow

Operating Cash Flow

-$11M

Free Cash Flow

-$11M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$67M

Total Liabilities

$105M

Stockholders' Equity

-$37M

Cash & Equivalents

$2M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$13M	$7M	+93.3%
Gross Profit	$13M	$6M	+100.1%
Operating Income	-$12M	-$18M	+34.3%
Net Income	-$20M	-$20M	+1.0%